Bot Detector
IJPC Seal
Download FREE Sample Issue or Article
LEARN MORE
Subscribe Today
A subscription to IJPC provides on-line access to full-text, full-color, printable PDF copies of your subscribed issues, individual articles, and purchased archives.

Compounded Pimobendan for Canine Chronic Degenerative Mitral Valve Disease and Pulmonary Hypertension

Author(s):  Helms Scott R, Fox Samantha, Mixon William, Vail Jane

Issue:  Jan/Feb 2012 - Volume 16, Number 1
View All Articles in Issue

Page(s):  34-41

Compounded Pimobendan for Canine Chronic Degenerative Mitral Valve Disease and Pulmonary Hypertension Page 1
Compounded Pimobendan for Canine Chronic Degenerative Mitral Valve Disease and Pulmonary Hypertension Page 2
Compounded Pimobendan for Canine Chronic Degenerative Mitral Valve Disease and Pulmonary Hypertension Page 3
Compounded Pimobendan for Canine Chronic Degenerative Mitral Valve Disease and Pulmonary Hypertension Page 4
Compounded Pimobendan for Canine Chronic Degenerative Mitral Valve Disease and Pulmonary Hypertension Page 5
Compounded Pimobendan for Canine Chronic Degenerative Mitral Valve Disease and Pulmonary Hypertension Page 6
Compounded Pimobendan for Canine Chronic Degenerative Mitral Valve Disease and Pulmonary Hypertension Page 7
Compounded Pimobendan for Canine Chronic Degenerative Mitral Valve Disease and Pulmonary Hypertension Page 8

Download in electronic PDF format for $75

Abstract:  Pimobendan (Vetmedin) is an effective treatment for canine chronic degenerative mitral valve disease and dilated cardiomyopathy. In an off-label use, it may also be of benefit for the treatment of pulmonary hypertension in dogs. In this report, we describe the effects of a palatable customized oral form of pimobendan used with both compounded and commercially manufactured conventional drug therapy to treat degenerative mitral valve disease and pulmonary hypertension in two small dogs. For those patients, who resisted many types of oral medication, the standard manufactured dose of pimobendan was inappropriate. Formulations of the preparations used to treat the patients described in this report are provided for easy reference. It should be noted that at the time of this writing, Boehringer Ingelheim GmbH (Ingelheim am Rhein, Germany), the manufacturer of pimobendan, has expressed concern about the stability of that agent in aqueous compounded form. To our knowledge, no current data confirming the stability or bioequivalence of compounded pimobendan exist.

Related Keywords: Scott R. Helms, DVM, Diplomate ABVP, Samantha Fox, BA, CPhT, William Mixon, RPh, MS, FIACP, Jane Vail, canine chronic degenerative mitral valve disease, dilated cardiomyopathy, dogs, phosphodiesterase 3 inhibitor, pimobendan, case reports, enalapril, sildenafil citrate, formulations, furosemide

Related Categories: FORMULATIONS, VETERINARY, CASE REPORTS, CARDIOLOGY, INFORMATION RESOURCES

Printer-Friendly Version



Related Articles from IJPC
Title/Author
(Click for Abstract / Details / Purchase)
Issue/​Page
View/Buy
Compounded Pimobendan for Canine Chronic Degenerative Mitral Valve Disease and Pulmonary Hypertension
Helms Scott R
, Fox Samantha, Mixon William, Vail Jane
Jan/Feb 2012
Pg. 34-41

The Treatment of Canine Atopic Disease
Davidson Gigi S
May/Jun 2002
Pg. 210-215

Treating Canine Hepatic Disease
Davidson Gigi S
May/Jun 2003
Pg. 188-191

Calculations
Prince Shelly J
Sep/Oct 2002
Pg. 387

Glutaraldehyde-treated Autologous Pericardium Used in Valve Repairs
McElhiney Linda F
Jan/Feb 2012
Pg. 12-16

Basics of Compounding for Raynaud's Disease
Glasnapp Andrew
Jul/Aug 2003
Pg. 288-291

Treatment of Canine Pulmonary Hypertension: Is Tadalafil an Appropriate Alternative to Sildenafil?
Wung Deanna
Jan/Feb 2013
Pg. 24-27

Veterinary Compounding for Hyperadrenocorticism (Cushing's Disease) in Dogs
Davidson Gigi S
Sep/Oct 2002
Pg. 332-336

Conservative Management of Chronic Kidney Disease in Cats: Recommendations for Veterinarians and Compounding Pharmacists
Meadows Richard L
, Muller George
Sep/Oct 2010
Pg. 382-394

Transdermal Amlodipine Besylate in Lipoderm for the Treatment of Feline Hypertension: A Report of Two Cases
Mixon William
, Helms Scott R
Sep/Oct 2008
Pg. 392-397

Application of Sildenafil for Pulmonary Hypertension in Canines and Foals
Davidson Gigi S
Nov/Dec 2006
Pg. 405-408

Case Reports: Osteomyelitis in a Young Draft Horse; Quarter Horse Gelding with Chronic Obstructive Pulmonary Disease
Patterson Donna
, Ford Peter R, Gallon Marlene D
Jul/Aug 1997
Pg. 242-243

Compounding in the Pharmacy Curriculum: Beyond the Basics
Hinkle Amanda R
, Newton Gail D
May/Jun 2004
Pg. 181-185

Quality Control: Undecided About Buying an In-House Water Purification System? Pros, Cons, and Caveats That May Provide the Answers You Need
Mixon William
, Fox Samantha, Barnes Danny, Stuart William, Betlach Verne, Hall Richard M, Biller Jeremy, Kelly Russ, Janik Peter, Purcell Julian
Nov/Dec 2011
Pg. 480-487

Compounding for Cancer in Companion Animals
Mixon William
, Northrup Nicole, Vail Jane
Jan/Feb 2009
Pg. 42-49

Feline Ophthalmic Disease: Feline Herpesvirus and Systemic Hypertension
Davidson Michael G
Mar/Apr 2001
Pg. 92-94

Levorphanol, Methadone, and the Management of Intractable Chronic Pain: An Interview with Kerry Schmidt, BA, MBA; Jack P. McNulty, MD, FACP; and George B. Muller, RPh
Vail Jane
Jan/Feb 2006
Pg. 9-11

Compounding for Diseases of the Oral Cavity: A discussion with Stu Sommerville, RPh
Vail Jane
Jan/Feb 2002
Pg. 16-18

PreScription: The International Academy of Compounding Pharmacists Remembers Evelyn Timmons, RPh, FIACP, and George Roentsch, RPh, FIACP
Karolchyk Scott
Jan/Feb 2012
Pg. 4

View Sample
Compounding for Juvenile Idiopathic Arthritis and Other Pediatric Rheumatic Diseases
Harrington Amy
, Williams LaVonn
Jul/Aug 2022
Pg. 293-296

Return to Top